SAB Biotherapeutics (SABS) Revenue (2021 - 2024)
SAB Biotherapeutics posted quarterly Revenue of $114698.0 for Q4 2024, down 62.4% year-on-year from $305011.0 in Q1 2024, and down 56.41% on a QoQ basis from $263137.0 in Q2 2024.
SAB Biotherapeutics (SABS) has 4 years of Revenue data on file, last reported at $114698.0 in Q4 2024.
- For the quarter ending Q4 2024, Revenue fell 62.4% year-over-year to $114698.0; the trailing twelve-month figure through Dec 2024 stood at $1.3 million (down 40.94% YoY), and the FY2024 full-year result was $1.3 million, down 40.94% from the prior year.
- Revenue for Q4 2024 stood at $114698.0, down from $263137.0 in the prior quarter.
- Across five years, Revenue topped out at $18.2 million in Q2 2021 and bottomed at $85518.0 in Q2 2023.
- The 4-year median for Revenue is $2.2 million (2022), against an average of $5.9 million.
- The widest annual swing landed in 2023, when Revenue tumbled 98.65%; it then surged 207.7% in 2024.
- A 4-year view of Revenue shows it stood at $11.1 million in 2021, then sank by 80.46% to $2.2 million in 2022, then slumped by 85.88% to $305011.0 in 2023, then slumped by 62.4% to $114698.0 in 2024.
- The last three Revenue figures came in at $114698.0 (Q4 2024), $263137.0 (Q2 2024), and $944575.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | SAB Biotherapeutics | 192.81 Mn | 192.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 114,698.00 |
| Jun 30, 2024 | 263,137.00 |
| Mar 31, 2024 | 944,575.00 |
| Dec 31, 2023 | 305,011.00 |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 85,518.00 |
| Mar 31, 2023 | 581,101.00 |
| Dec 31, 2022 | 2.16 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Mar 31, 2022 | 11.80 Mn |
| Dec 31, 2021 | 11.06 Mn |
| Sep 30, 2021 | 14.68 Mn |
| Jun 30, 2021 | 18.21 Mn |
| Mar 31, 2021 | 16.93 Mn |